Category Archives: Uncategorized

Macular vessel density a useful marker for glaucoma progression

This prospective longitudinal study characterized the morphologic and vascular changes in glaucomatous eyes. Source: AAO

Posted on: Sep 24 2020
By: Saratoga Opthalmology
Leave a response

The relationship between 5-ARI and macular abnormalities

This retrospective study evaluated the association between the use of 5α-reductase inhibitor (5-ARI) in men and macular abnormalities. Source: AAO

Posted on: Sep 23 2020
By: Saratoga Opthalmology
Leave a response

Topical interferon alpha 2b may increase risk of corneal melt in predisposed patients

This case report describes corneal melt in a patient treated with topical interferon (INF) alpha 2b for conjunctival intraepithelial neoplasia (CIN) and carcinoma in situ of the cornea. Source: AAO

Posted on: Sep 21 2020
By: Saratoga Opthalmology
Leave a response

Week in review: COVID candidate, new Quest, dopamine boost

This week, Aldeyra Therapeutics gets clearance to test their drug for COVID-19, Oculus announces the new and improved Quest 2 VR headset and a common Parkinson drug shows promise for AMD. Source: AAO

Posted on: Sep 18 2020
By: Saratoga Opthalmology
Leave a response

External DCR with 1-week intubation shows good long-term outcomes

This paper reports the 4-year outcomes of uncomplicated external dacryocystorhinostomy (DCR) with a 1-week intubation. Source: AAO

Posted on: Sep 18 2020
By: Saratoga Opthalmology
Leave a response

Deep learning system is equal to or better than experts at classifying optic disc abnormalities

This study compared the diagnostic performance of an artificial intelligence deep learning system with that of expert neuro-ophthalmologists in classifying optic disc appearance. Source: AAO

Posted on: Sep 17 2020
By: Saratoga Opthalmology
Leave a response

Persistent culture positivity in fungal keratitis may indicate need for therapeutic PK

Researchers evaluated the usefulness of repeat cultures after starting antifungal medication for predicting outcomes in fungal keratitis. Source: AAO

Posted on: Sep 16 2020
By: Saratoga Opthalmology
Leave a response

XEN45 appears safe and effective through 2 years

Researchers report the efficacy and safety of XEN45 at 2 years. Source: AAO

Posted on: Sep 14 2020
By: Saratoga Opthalmology
Leave a response

Week in review: Hot water, turmeric cure, needle puncture

This week, 2 pharma giants are slapped with a hefty $526 million fine, turmeric shows promise for canine uveitis and researcher share a cautionary tale of anti-VEGF for ROP. Source: AAO